Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07231458 |
| Title | A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Abalos Therapeutics GmbH |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Charite-Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF) | RECRUITING | Berlin | 12200 | Germany | Details | |
| Universitaetsklinikum Tuebingen | RECRUITING | Tübingen | 72076 | Germany | Details | |
| Vall d'Hebron Institut d'Oncologia | RECRUITING | Barcelona | 08035 | Spain | Details | |
| Hospital Universitario Fundacion Jimenez Diaz | RECRUITING | Madrid | 28040 | Spain | Details | |
| The START Center for Cancer Care - CIOCC | RECRUITING | Madrid | 28050 | Spain | Details |